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distribution and the sites of preferred fragmentation of the circulating DNA significantly change. Using a training set of a liver cancer patient, the authors define a 'cancer-associated' set of preferred fragment ends and then differentiated (with an area under the curve value of 0.88) HCC patients (n = 90) from healthy, liver disease and liver cirrhosis controls (n = 32, 67, 36) by their circulating DNA fragments. This approach could present a novel way to detect HCC, despite its many genetic manifestations. (1) future science group
